BRIEF-Health Canada approves Opdivo for treatment of advanced or metastatic renal cell carcinoma
April 25, 2016 at 15:29 PM EDT
* Bristol-Myers Squibb Canada says Health Canada approves Opdivo for treatment of advanced or metastatic renal cell carcinoma Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780; )
